ALK and neuroblastoma: Results from this study revealed a relative low percentage of recurrent somatic mutations in NB, being the most significant, in terms of frequency, those affecting ALK (9.2%), PTPN11 (2.9%), ATRX (2.5%), MYCN (1.7%) and NRAS (0.83%) [22].